Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Planning update |
| Buyer: | LEIDOS SUPPLY, LIMITED |
| Main Category: | Goods |
| Procurement Method: | — |
| Tender Status: | Pre-tender |
| Estimated Value (ex. VAT): | £5,000,000 |
| Estimated Value (inc. VAT): | £6,000,000 |
| Release Date: | 22 May 2026 |
| Application Deadline: | — |
| Contract Start Date: | 20 May 2027 (Estimated) |
| Contract End Date: | 20 May 2031 (Estimated) |
| Contract Duration: | 4.1 years |
| Procurement ID (OCID): | ocds-h6vhtk-06a1ec |
| Notice Reference: | 048143-2026 |
All 2 notices for this procurement, oldest first.
LSL/MED/0246 The Supply of Tranexamic Acid Auto-Injector (TXA AI)
LSL/MED/0246 The Supply of Tranexamic Acid Auto-Injector (TXA AI)
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
LSL/MED/0246 Procurement description Provide sufficient information to understand the scope of the procurement. In April 2015 the MOD signed a thirteen year contract with Leidos Europe Ltd to provide the procurement and inventory management of commodity items (as well as the storage and distribution services) historically provided in-house by the Logistic Commodities and Services Operating Centre. Leidos, working with the MOD, will transform the way these services are delivered to ensure requirements continue to be met whilst providing best value for money for the department. The organisation delivering these services is known as Team Leidos. Team Leidos would like to make markets aware that we are intending to investigate innovative approaches to fill our Supply of Tranexamic Acid Auto-Injector (TXA AI) requirements. We are actively seeking innovative, commercially viable solutions to meet this critical requirement. We invite industry partners to engage with us and bring forward novel approaches that can accelerate delivery, enhance operational effectiveness, and meet the evolving needs of Defence. We are interested in an Auto-Injector device containing 1g of Tranexamic Acid (TXA) in no greater than 3ml volume. It is the aim of this Preliminary Market Engagement Notice (PMEN) to encourage companies, suppliers, or manufacturers to make us aware and provide as much information as they are comfortable with, to help decide the future strategy for the range. Team Leidos wishes to generate interest, information and views with other companies to understand the current market innovation and gain useful intelligence that can help our requirement. To request the PMEN documents please contact: Name and Email address Christina.brice103@teamleidos.mod.uk In the email request the documents related the Supply of Tranexamic Acid Auto-Injector (TXA AI). The documents will then be sent for completion and should be returned to the same email addresses before the deadline. Responses are required as soon as possible to inform next steps, but the PMEN will remain open until 27/07/2026 The value of this framework is estimated to be between £4,000,000 - £5,000,000
Published contracts in the last 12 months
131
total contracts
£1489.2m
total value
£14,892,201
average contract size
Typical categories
LSL/MED/0246 The Supply of Tranexamic Acid Auto-Injector (TXA AI)
LEIDOS SUPPLY, LIMITED · WAC-600964
The Supply of Oils, Lubricants, and Associated Products
LEIDOS SUPPLY, LIMITED · WAC-599233
The Supply of DEXIS IXS Digital Intra Oral Sensors
LEIDOS SUPPLY, LIMITED · WAC-596621
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Estimated Value
£5,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →